Clinical Research Directory
Browse clinical research sites, groups, and studies.
Demographics, Clinical Characteristics and Outcomes in Resected Non-Small Cell Lung Cancer Patients Receiving Immunotherapy in Europe and Canada
Sponsor: Bristol-Myers Squibb
Summary
This study uses existing medical records to better understand how immunotherapy is used in people in Europe and Canada with non-small cell lung cancer (NSCLC) who undergo surgery. It looks at participant characteristics, treatments received before and after surgery, and outcomes such as survival.
Official title: Real-World Demographics, Clinical Characteristics and Outcomes in Resected Non-Small Cell Lung Cancer Patients Receiving Immunotherapy in Europe and Canada
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
300
Start Date
2026-02-28
Completion Date
2027-03-31
Last Updated
2026-07-21
Healthy Volunteers
No
Conditions
Interventions
nivolumab
As per product label
pembrolizumab
As per product label
durvalumab
As per product label
Locations (1)
IQVIA
London, United Kingdom